Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
UNLABELLED: Poor postnatal growth after preterm birth does not match the normal rapid growth in utero and is associated with preterm morbidities. Insulin-like growth factor 1 (IGF-1) axis is the major hormonal mediator of growth in utero, and levels of IGF-1 are often very low after preterm birth. We reviewed the role of IGF-1 in foetal development and the corresponding preterm perinatal period to highlight the potential clinical importance of IGF-1 deficiency in preterm morbidities. CONCLUSION: There is a rationale for clinical trials to evaluate the potential benefits of IGF-1 replacement in very preterm infants.
Description
Keywords
Development, Foetus, Insulin-like growth factor 1, Metabolism, Preterm infant, Animals, Fetal Development, Hormone Replacement Therapy, Humans, Infant, Newborn, Infant, Premature, Insulin-Like Growth Factor I
Journal Title
Acta Paediatr
Conference Name
Journal ISSN
0803-5253
1651-2227
1651-2227
Volume Title
105
Publisher
Wiley
Publisher DOI
Sponsorship
European Commission (305485)
This work was supported by a European Commission FP7 project 305485 PREVENT-ROP grant to all of the authors.